TSX steady as miners, Valeant climb; financials slip
By John Tilak
TORONTO (Reuters) - Canada's main stock index was little changed on Tuesday as an advance in the materials sector and gains in Valeant Pharmaceuticals International Inc (VRX.TO: Quote) helped offset weakness in some financial shares.
Valeant shares jumped 3.7 percent after the drugmaker said that when it announces a sweetened takeover offer for Allergan Inc (AGN.N: Quote) on May 28, it will not be the all-cash bid that had been expected.
Opening after a long weekend in Canada, the Toronto stock market's small gain follows declines in the previous three sessions. It is up 6.6 percent so far this year.
Some investors said that markets have been ignoring concerns about the pace of economic and earnings growth, raising worries about extended stock valuations.
"The markets assumed all of the positives and didn't incorporate any of the negatives," said Subodh Kumar, chief investment strategist at Subodh Kumar & Associates, noting that investors are now factoring in geopolitical uncertainty, sluggish global growth and weaker-than-expected corporate revenue growth.
"There is very little room for valuation expansion and there's potential for a pullback in the equity markets," he added. "My basic view is that the markets probably won't end the year much higher than (where) they started."
The Toronto Stock Exchange's S&P/TSX composite index .GSPTSE closed up 10.45 points, or 0.07 percent, at 14,525.19.
Kumar expects a correction in the Canadian benchmark midway through the year and a recovery towards the end of the year. Continued...